Related Experiment Video
Updated: Feb 28, 2026
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Primary cutaneous post liver transplant lymphoproliferative disorder (PTLD) successfully treated with radiotherapy
Aizuri Murad1, Kieran Sheahan2, Brian Kirby1
1a Department of Dermatology , St. Vincent's University Hospital , Dublin , Ireland.
Aim:
A case of primary cutaneous post liver transplant lymphoproliferative disorder (PTLD) mimicking squamous cell carcinoma-in-situ is presented.
Methods:
Lesions mimicking SCC-in-situ were confirmed to be PTLD on histopathology and immunohistochemistry. Immunosuppression was gradually reduced and the lesions were successfully treated with 50 gray (Gy) in 25 fractions of radiotherapy.
Results:
There was no recurrence of lesions at 3 months follow-up.
Conclusion:
Radiotherapy is an effective form of cutaneous directed treatment for localized PTLD.
